©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 111914
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.111914
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.111914
Table 6 Serial alpha-fetoprotein levels measured at different time points, mean ± SD
| Group | Before treatment | Day 1 after treatment | Day 10 after treatment | Day 20 after treatment | Day 25 after treatment | P value |
| Low AFP group | 65.2 ± 20.1 | 72.5 ± 18.3 | 85.4 ± 22.6 | 92.1 ± 25.4 | 98.3 ± 28.7 | < 0.001 |
| Medium AFP group | 148.3 ± 35.6 | 160.8 ± 40.2 | 175.6 ± 45.3 | 190.2 ± 50.1 | 205.4 ± 55.8 | < 0.001 |
| High AFP group | 320.5 ± 80.4 | 340.2 ± 85.6 | 365.7 ± 90.3 | 380.1 ± 95.2 | 395.6 ± 98.5 | < 0.001 |
| P value1 | 0.984 | 0.932 | 0.018 | 0.006 | 0.003 |
- Citation: Guo WB, Wang LY, Guo XJ, Yang J, Li W, Shen FY, Li YT, Yang JH, Tai WL. Prognostic value of serum alpha-fetoprotein kinetics in liver failure on artificial liver support. World J Gastroenterol 2025; 31(37): 111914
- URL: https://www.wjgnet.com/1007-9327/full/v31/i37/111914.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i37.111914